Why is polypharmacy increasing in aged care facilities? The views of Australian health care professionals

Rationale, aims and objectives The prevalence of polypharmacy in residential aged care facilities (RACFs) is high and increasing. Although not necessarily inappropriate, polypharmacy has been associated with drug interactions, adverse drug events, geriatric syndromes and hospital admissions. The aim...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JOURNAL OF EVALUATION IN CLINICAL PRACTICE 2016-10, Vol.22 (5), p.677-682
Hauptverfasser: Jokanovic, Natali, Tan, Edwin C. K., Dooley, Michael J., Kirkpatrick, Carl M., Elliott, Rohan A., Bell, J. Simon
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Rationale, aims and objectives The prevalence of polypharmacy in residential aged care facilities (RACFs) is high and increasing. Although not necessarily inappropriate, polypharmacy has been associated with drug interactions, adverse drug events, geriatric syndromes and hospital admissions. The aim of this study was to identify and prioritize factors contributing to the increasing prevalence of polypharmacy in RACFs. Methods Seventeen health care professionals from metropolitan and regional Victoria and South Australia identified and prioritized factors using a modified nominal group technique. Results The top five factors ranked from most important to fifth most important were ‘changes in resident mix’, ‘increasing numbers of prescribers and the reluctance of one prescriber to discontinue a medicine commenced by another prescriber’, ‘better adherence to clinical practice guidelines’, ‘increasing reliance on locums’ and ‘greater recognition and pharmacological management of pain’. Conclusions Reasons for the increase in polypharmacy are multifactorial. Understanding the factors contributing to polypharmacy may help to guide future research and develop interventions to manage polypharmacy in RACFs.
ISSN:1356-1294
1365-2753
DOI:10.1111/jep.12514